Donor EBV at the time of hematopoietic cell transplantation: Is it time to adopt molecular assays?

J Clin Virol. 2018 May:102:32-33. doi: 10.1016/j.jcv.2018.02.012. Epub 2018 Feb 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Agents, Immunological / pharmacology
  • Antineoplastic Agents, Immunological / therapeutic use
  • DNA, Viral / blood*
  • Epstein-Barr Virus Infections / drug therapy
  • Epstein-Barr Virus Infections / virology*
  • Female
  • Graft vs Host Disease / prevention & control*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Rituximab / pharmacology
  • Rituximab / therapeutic use
  • Tissue Donors*
  • Virus Activation / drug effects
  • Young Adult

Substances

  • Antineoplastic Agents, Immunological
  • DNA, Viral
  • Rituximab